• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当今的肠促胰岛素概念。

The incretin concept today.

作者信息

Creutzfeldt W

出版信息

Diabetologia. 1979 Feb;16(2):75-85. doi: 10.1007/BF01225454.

DOI:10.1007/BF01225454
PMID:32119
Abstract
  1. The insulinogenic factor of the gastrointestinal mucosa named "incretin" is only one part of the complex enteroinsular axis. --2. Of the chemically defined gastrointestinal hormones GIP is the strongest incretin candidate. --3. Because of the dual function of GIP as gastrone and insulinotropic substance several safeguards against GIP-mediated insulin hypoglycaemia exist. --4. No pathological condition has yet been found which is causally related to hyper- or hyposecretion of GIP. However, an exaggerated GIP response (usually secondary to the disease) may participate in the pathogenesis of hyperinsulinaemia of patients with obesity and duodenal ulcer. --5. The injection of GIP antibodies only partially abolishes the incretin effect. Therefore, GIP, although important, is not the only incretin.
摘要
  1. 胃肠道黏膜中被称为“肠促胰岛素”的胰岛素生成因子只是复杂的肠胰岛轴的一部分。

  2. 在化学性质明确的胃肠道激素中,胃抑肽是最强的肠促胰岛素候选物。

  3. 由于胃抑肽具有胃泌素和促胰岛素物质的双重功能,因此存在多种防止胃抑肽介导的胰岛素低血糖的保护机制。

  4. 尚未发现与胃抑肽分泌过多或过少存在因果关系的病理状况。然而,胃抑肽反应过度(通常继发于疾病)可能参与肥胖症和十二指肠溃疡患者高胰岛素血症的发病机制。

  5. 注射胃抑肽抗体只能部分消除肠促胰岛素效应。因此,胃抑肽虽然很重要,但不是唯一的肠促胰岛素。

相似文献

1
The incretin concept today.当今的肠促胰岛素概念。
Diabetologia. 1979 Feb;16(2):75-85. doi: 10.1007/BF01225454.
2
Gastric inhibitory polypeptide.胃抑制性多肽
Clin Gastroenterol. 1980 Sep;9(3):679-98.
3
Disturbances of the entero-insular axis.肠-胰岛轴的紊乱。
Scand J Gastroenterol Suppl. 1983;82:111-9.
4
New developments in the incretin concept.肠促胰岛素概念的新进展。
Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990.
5
Enteroinsular axis.肠岛轴
Baillieres Clin Endocrinol Metab. 1988 May;2(2):359-73. doi: 10.1016/s0950-351x(88)80037-5.
6
Gastrointestinal peptides--rôle in pathophysiology and disease.胃肠肽——在病理生理学和疾病中的作用
Scand J Gastroenterol Suppl. 1982;77:7-20.
7
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.新型(Pro3)GIP拮抗剂和艾塞那肽(9 - 39)酰胺对肥胖糖尿病(ob/ob)小鼠中GIP和GLP - 1诱导的环磷酸腺苷生成、胰岛素分泌及餐后胰岛素释放的影响:GIP是主要生理性肠促胰岛素的证据
Diabetologia. 2003 Feb;46(2):222-30. doi: 10.1007/s00125-002-1028-x. Epub 2003 Feb 12.
8
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.肠促胰岛素激素在糖尿病和非糖尿病患者胰岛素分泌调节中的作用。
Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E199-206. doi: 10.1152/ajpendo.00545.2003.
9
The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.内源性胃抑肽作为葡萄糖依赖性促胰岛素分泌激素在十二指肠溃疡患者中起调节作用的证据。
Clin Endocrinol (Oxf). 1983 Sep;19(3):345-53. doi: 10.1111/j.1365-2265.1983.tb00008.x.
10
Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass.肥胖症患者口服葡萄糖后及空肠回肠旁路术后胃抑制多肽(GIP)的释放与肠促胰岛素效应
Scand J Gastroenterol. 1980;15(4):489-95. doi: 10.3109/00365528009181506.

引用本文的文献

1
Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders.肠促胰岛素与代谢相关脂肪性肝病:内分泌与肝脏疾病的交汇点
Curr Obes Rep. 2025 Jun 25;14(1):56. doi: 10.1007/s13679-025-00646-8.
2
DPP-IV and FAS inhibitory peptides: therapeutic alternative against diabesity.二肽基肽酶-IV(DPP-IV)和脂肪酸合酶(FAS)抑制肽:对抗糖尿病肥胖症的治疗选择
J Diabetes Metab Disord. 2025 Apr 10;24(1):100. doi: 10.1007/s40200-025-01613-9. eCollection 2025 Jun.
3
Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes.作为宿主-微生物同工酶的S9B家族微生物二肽基肽酶

本文引用的文献

1
On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane.十二指肠黏膜酸提取物治疗糖尿病
Biochem J. 1906;1(1):28-38. doi: 10.1042/bj0010028.
2
PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.血浆胰岛素对口服和静脉注射葡萄糖的反应。
J Clin Endocrinol Metab. 1964 Oct;24:1076-82. doi: 10.1210/jcem-24-10-1076.
3
NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.口服葡萄糖耐量的新解读
Sci Adv. 2025 Apr 4;11(14):eads5721. doi: 10.1126/sciadv.ads5721. Epub 2025 Apr 2.
4
Glucose-dependent insulinotropic polypeptide (GIP).葡萄糖依赖性促胰岛素多肽(GIP)。
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
5
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.肠促胰岛素生理中的葡萄糖依赖性促胰岛素多肽:在健康与疾病中的作用
Endocr Rev. 2025 Jul 15;46(4):479-500. doi: 10.1210/endrev/bnaf006.
6
Nutritional state-dependent modulation of insulin-producing cells in .营养状态对……中胰岛素生成细胞的调节
Elife. 2025 Jan 29;13:RP98514. doi: 10.7554/eLife.98514.
7
Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis.选择内分泌紊乱和外泌体在早期 PDAC 诊断中的应用。
Int J Mol Sci. 2024 Nov 13;25(22):12159. doi: 10.3390/ijms252212159.
8
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review.胰高血糖素样肽-1(GLP-1)受体激动剂:通过全面文献综述探讨其对糖尿病、肥胖症和心血管健康的影响
Cureus. 2024 Sep 1;16(9):e68390. doi: 10.7759/cureus.68390. eCollection 2024 Sep.
9
Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery: a multi-ancestry study in 10 960 individuals from 9 biobanks.似然遗传因素与胰高血糖素样肽-1受体激动剂和减肥手术导致的体重减轻之间的关联:一项对来自9个生物样本库的10960名个体的多血统研究。
medRxiv. 2025 Jan 8:2024.09.11.24313458. doi: 10.1101/2024.09.11.24313458.
10
QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award.对斯韦特兰娜·莫伊索夫、乔尔·哈贝纳和洛特·比耶鲁·克努森的问答:2024年拉斯克~德巴基临床医学研究奖获得者
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2416868121. doi: 10.1073/pnas.2416868121. Epub 2024 Sep 19.
Lancet. 1964 Jul 4;2(7349):20-1. doi: 10.1016/s0140-6736(64)90011-x.
4
A study of the diabetic syndrome produced in rats by anti-insulin serum.一项关于抗胰岛素血清诱导大鼠产生糖尿病综合征的研究。
Diabetes. 1963 Jan-Feb;12:73-81. doi: 10.2337/diab.12.1.73.
5
Quantitative relations between the oral and intravenous glucose tolerance curves.口服与静脉葡萄糖耐量曲线之间的定量关系。
Am J Physiol. 1954 Dec;179(3):435-8. doi: 10.1152/ajplegacy.1954.179.3.435.
6
Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.血浆胰岛素对口服及静脉注射葡萄糖的反应:对正常及糖尿病受试者的研究。
J Clin Invest. 1967 Dec;46(12):1954-62. doi: 10.1172/JCI105685.
7
Carbohydrate metabolism in duodenal ulcer patients.十二指肠溃疡患者的碳水化合物代谢
Gut. 1967 Aug;8(4):325-31. doi: 10.1136/gut.8.4.325.
8
Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.促胰液素、缩胆囊素或胃泌素对人体内分泌胰腺对葡萄糖或精氨酸给药反应的影响。
J Clin Invest. 1969 Apr;48(4):745-57. doi: 10.1172/JCI106032.
9
Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man.胃泌素及其C末端四肽对人体胰岛素分泌的影响。
Acta Endocrinol (Copenh). 1971 Jan;66(1):169-76. doi: 10.1530/acta.0.0660169.
10
Glucose turnover and insulin secretion in dogs with pancreatic allografts.胰腺同种异体移植犬的葡萄糖代谢率和胰岛素分泌
Diabetologia. 1970 Aug;6(4):441-4. doi: 10.1007/BF01212079.